Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 347

1.

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.

Ferrari S, Adachi JD, Lippuner K, Zapalowski C, Miller PD, Reginster JY, Törring O, Kendler DL, Daizadeh NS, Wang A, O'Malley CD, Wagman RB, Libanati C, Lewiecki EM.

Osteoporos Int. 2015 Jun 12. [Epub ahead of print]

PMID:
26068295
2.

Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report.

Palcu P, Dion N, Ste-Marie LG, Goltzman D, Radziunas I, Miller PD, Jamal SA.

Am J Kidney Dis. 2015 Jun;65(6):933-6. doi: 10.1053/j.ajkd.2015.01.025. Epub 2015 Apr 2.

PMID:
25843705
3.

Update on osteoporosis from the 2014 Santa Fe Bone symposium.

Lewiecki EM, Bilezikian JP, Binkley N, Hans D, Krueger D, Miller PD, Oates M, Shane E.

Endocr Res. 2015;40(2):106-19. doi: 10.3109/07435800.2015.1005746. Epub 2015 Mar 24.

PMID:
25803304
4.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW.

N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.

PMID:
25692915
5.

Fracture incidence in a large cohort of men age 30 years and older with osteoporosis.

Manthripragada AD, O'Malley CD, Gruntmanis U, Hall JW, Wagman RB, Miller PD.

Osteoporos Int. 2015 May;26(5):1619-27. doi: 10.1007/s00198-015-3035-z. Epub 2015 Jan 24.

PMID:
25616508
6.

A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.

Langdahl BL, Teglbjærg CS, Ho PR, Chapurlat R, Czerwinski E, Kendler DL, Reginster JY, Kivitz A, Lewiecki EM, Miller PD, Bolognese MA, McClung MR, Bone HG, Ljunggren Ö, Abrahamsen B, Gruntmanis U, Yang YC, Wagman RB, Mirza F, Siddhanti S, Orwoll E.

J Clin Endocrinol Metab. 2015 Apr;100(4):1335-42. doi: 10.1210/jc.2014-4079. Epub 2015 Jan 21.

PMID:
25607608
7.

Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.

Miller PD, McCarthy EF.

Semin Arthritis Rheum. 2015 Apr;44(5):477-82. doi: 10.1016/j.semarthrit.2014.09.005. Epub 2014 Sep 16.

PMID:
25312241
8.

Authors' response.

Miller PD Jr, McEntire ML, Marlow NM, Gellin RG.

J Periodontol. 2014 Sep;85(9):1159-60. doi: 10.1902/jop.2014.140060. No abstract available.

PMID:
25168259
9.

Chronic kidney disease and osteoporosis: evaluation and management.

Miller PD.

Bonekey Rep. 2014 Jun 25;3:542. doi: 10.1038/bonekey.2014.37. eCollection 2014. Review.

10.

Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.

Kleerekoper M, Greenspan SL, Lewiecki EM, Miller PD, Kendler DL, Maricic M, Keaveny TM, Kopperdahl DL, Ruff VA, Wan X, Janos B, Krohn K.

J Bone Joint Surg Am. 2014 Jun 4;96(11):e90. [Epub ahead of print]

PMID:
24897747
11.

Bone disease in CKD: a focus on osteoporosis diagnosis and management.

Miller PD.

Am J Kidney Dis. 2014 Aug;64(2):290-304. doi: 10.1053/j.ajkd.2013.12.018. Epub 2014 Apr 13. Review.

PMID:
24726630
12.

Effects of up to 5 years of denosumab treatment on bone histology and histomorphometry: the FREEDOM study extension.

Brown JP, Reid IR, Wagman RB, Kendler D, Miller PD, Jensen JE, Bolognese MA, Daizadeh N, Valter I, Zerbini CA, Dempster DW.

J Bone Miner Res. 2014 Sep;29(9):2051-6. doi: 10.1002/jbmr.2236.

PMID:
24692050
13.

Bone density testing: science, the media, and patient care.

Rothman MS, Miller PD, Lewiecki E, Bilezikian JP.

Curr Osteoporos Rep. 2014 Jun;12(2):227-9.

PMID:
24659466
14.

Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium.

Lewiecki EM, Bilezikian JP, Bonewald L, Compston JE, Heaney RP, Kiel DP, Miller PD, Schousboe JT.

J Clin Densitom. 2014 Jul-Sep;17(3):330-43. doi: 10.1016/j.jocd.2013.11.006. Epub 2014 Mar 7.

PMID:
24613387
15.

PINP as a biological response marker during teriparatide treatment for osteoporosis.

Krege JH, Lane NE, Harris JM, Miller PD.

Osteoporos Int. 2014 Sep;25(9):2159-71. doi: 10.1007/s00198-014-2646-0. Epub 2014 Mar 6.

16.

Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005-2008: is treatment with bisphosphonates an option?

Lubwama R, Nguyen A, Modi A, Chirovsky D, Miller PD.

Osteoporos Int. 2014 May;25(5):1607-15. doi: 10.1007/s00198-014-2645-1. Epub 2014 Feb 28. Erratum in: Osteoporos Int. 2014 Dec;25(12):2841. Diana, C [corrected to Chirovsky, D].

PMID:
24577347
17.

Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.

Zangeneh F, Clarke BL, Hurley DL, Watts NB, Miller PD.

Endocr Pract. 2014 May;20(5):500-16. doi: 10.4158/EP12291.RA.

PMID:
24325991
18.

Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis.

Lewiecki EM, Miller PD, Harris ST, Bauer DC, Davison KS, Dian L, Hanley DA, McClung MR, Yuen CK, Kendler DL.

J Clin Densitom. 2014 Oct-Dec;17(4):490-5. doi: 10.1016/j.jocd.2013.09.018. Epub 2013 Oct 25. Review.

PMID:
24206867
19.

Claim that primary care provides in excess of 80% NHS activity is wrong.

Miller PD.

BMJ. 2013 Oct 22;347:f6163. doi: 10.1136/bmj.f6163. No abstract available.

PMID:
24150666
20.

Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.

Miller PD, Recker RR, Harris S, Silverman S, Felsenberg D, Reginster J, Day BM, Barr C, Masanauskaite D.

Osteoporos Int. 2014 Jan;25(1):349-57. doi: 10.1007/s00198-013-2518-z. Epub 2013 Oct 18.

PMID:
24136103
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk